Funds and ETFs Sanofi India Limited

Equities

SANOFI

INE058A01010

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:49 2024-04-29 am EDT 5-day change 1st Jan Change
8,282 INR +0.05% Intraday chart for Sanofi India Limited +0.71% +2.66%

ETFs positioned on Sanofi India Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 4 M€ -4.41% -
0.01% 117 M€ +1.11% -
0.00% 34 M€ +2.14% -
0.00% 7 M€ +1.95% -
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SANOFI Stock
  4. Funds and ETFs Sanofi India Limited